Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vaccine ; 42(18): 3899-3915, 2024 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-38719691

RESUMO

Scrub typhus, a potentially life-threatening infectious disease, is attributed to bacteria Orientia tsutsugamushi (O. tsutsugamushi). The transmission of this illness to humans occurs through the bite of infected chiggers, which are the larval forms of mites belonging to the genus Leptotrombidium. In this research, we developed a subunit vaccine specifically designed to target outer membrane proteins. Immunodominant cytotoxic T-lymphocytes (CTLs), B- lymphocytes (BCLs), and major histocompatibility complex (MHC)- II epitopes were identified using machine learning and bioinformatics approaches. These epitopes were arranged in different combinations with the help of suitable linkers like AAY, KK, GPGPG and adjuvant (cholera toxin B) that resulted in a vaccine construct. Physiochemical properties were assessed, where the predicted solubility (0.571) was higher than threshold value. Tertiary structure was predicted using I-TASSER web server and evaluated using Ramachandran plot (94 % residues in most favourable region) and z-score (-6.04), which had shown the structure to have good stability and residue arrangement. Molecular docking with immune receptors, Toll-like receptor (TLR)-2 and -4 showed good residue interaction with 13 and 5 hydrogen bonds respectively. Molecular dynamics simulations of receptor-ligand complex provided the idea about the strong interaction having 1.524751 × 10-5 eigenvalue. Amino acid sequence of vaccine was converted to nucleotide sequence and underwent codon optimization. The optimized codon sequence was used for in-silico cloning, which provided idea about the possibility of synthesis of vaccine using E. coli as host. Overall, this study provided a promising blueprint for a scrub typhus vaccine, although experimental validation is needed for confirmation. Furthermore, it is crucial to acknowledge that while bioinformatics provides valuable insights, in-vitro and in-vivo studies are imperative for a comprehensive evaluation of vaccine candidate. Thus, the integration of computational predictions with empirical research is essential to validate the efficacy, safety, and real-world applicability of the designed vaccine against Scrub Typhus. Nevertheless, the findings are good to carry forward for in-vitro and in-vivo investigations.


Assuntos
Epitopos de Linfócito B , Epitopos de Linfócito T , Orientia tsutsugamushi , Tifo por Ácaros , Vacinas de Subunidades Antigênicas , Tifo por Ácaros/imunologia , Tifo por Ácaros/prevenção & controle , Orientia tsutsugamushi/imunologia , Humanos , Epitopos de Linfócito B/imunologia , Epitopos de Linfócito T/imunologia , Vacinas de Subunidades Antigênicas/imunologia , Simulação de Acoplamento Molecular , Vacinas Bacterianas/imunologia , Simulação por Computador , Biologia Computacional/métodos , Linfócitos T Citotóxicos/imunologia , Aprendizado de Máquina , Linfócitos B/imunologia , Receptor 2 Toll-Like/imunologia
2.
Vaccine ; 42(18): 3857-3873, 2024 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-38616437

RESUMO

Dengue becomes the most common life-threatening infectious arbovirus disease globally, with prevalence in the tropical and subtropical areas. The major clinical features include dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS), a condition of hypovolemic shock. Four different serotypes of the dengue virus, known as dengue virus serotype (DENV)- 1, 2, 3 and 4 can infect humans. Only one vaccine is available in the market, named Dengvaxia by Sanofi Pasteur, but there is no desired outcome of this treatment due the antibody dependent enhancement (ADE) of the multiple dengue serotypes. As of now, there is no cure against dengue disease. Our goal in this work was to create a subunit vaccine based on several epitopes that would be effective against every serotype of the dengue virus. Here, computational methods like- immunoinformatics and bioinformatics were implemented to find out possible dominant epitopes. A total of 21 epitopes were chosen using various in-silico techniques from the expected 133 major histocompatibility complex (MHC)- I and major histocompatibility complex (MHC)- II epitopes, along with 95 B-cell epitopes which were greatly conserved. Immune stimulant, non-allergenic and non-toxic immunodominant epitopes (super epitopes) with a suitable adjuvant (Heparin-Binding Hemagglutinin Adhesin, HBHA) were used to construct the vaccine. Following the physicochemical analysis, vaccine construct was docked with Toll-like receptors (TLRs) to predict the immune stimulation. Consequently, the optimal docked complex that demonstrated the least amount of ligand-receptor complex deformability was used to conduct the molecular dynamics analysis. By following the codon optimization, the final vaccine molecule was administered into an expressing vector to perform in-silico cloning. The robust immune responses were generated in the in-silico immune simulation analysis. Hence, this study provides a hope to control the dengue infections. For validation of the immune outcomes, in-vitro as well as in-vivo investigations are essential.


Assuntos
Vacinas contra Dengue , Vírus da Dengue , Dengue , Epitopos de Linfócito B , Sorogrupo , Vacinas contra Dengue/imunologia , Humanos , Vírus da Dengue/imunologia , Dengue/prevenção & controle , Dengue/imunologia , Epitopos de Linfócito B/imunologia , Simulação por Computador , Vacinas de Subunidades Antigênicas/imunologia , Biologia Computacional/métodos , Epitopos Imunodominantes/imunologia , Anticorpos Facilitadores/imunologia , Epitopos/imunologia , Anticorpos Antivirais/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA